Genome-wide association studies (GWAS) and polygenic risk scores (PRS) are two significant concepts in the field of genetics that have demonstrated promise as new tools

“First-of-its-Kind Data Underscore Importance of Early Use of Drug Therapy as a Primary Prevention,Especially for Those Living with Diabetes” Today, a new study revealed information

As part of the session “Efficacy. Engagement, and Sustainability of Dietary Management Options in Type 2 Diabetes – Time for a Reappraisal?” This Paper Was

As part of the session “Efficacy. Engagement, and Sustainability of Dietary Management Options in Type 2 Diabetes – Time for a Reappraisal?” This Paper Was

As part of the session “Real-World Hypoglycaemia in Older Adults with Diabetes” This Paper Was Presented By Drs Emily Tang, Ilana Peterson, Christine Board, Richard

As part of the session “Real-World Hypoglycaemia in Older Adults with Diabetes” This Paper Was Presented By Drs Gemma A. Lewis, Janet Cardwell, Sumudu Bujawansa,

Cardiovascular concerns are on the rise for people with diabetes, both in terms of acute and chronic complications, and a panel of scientists will discuss

A coordinated paradigm designed to overcome patient-, clinic-, and system-level barriers to care can significantly increase the prescribing of evidence-based drug therapies for people with

Retatrutide, a novel triple therapy, could continue the string of game-changing metabolic agents that began with semaglutide, a GLP-1 receptor agonist for type 2 diabetes

As part of the session “Where Lie the Keys to Type 2 Diabetes Prevention? Population Health or Personalized Medicine?”, This Paper Was Presented By Drs